Lv11
76 积分 2025-11-27 加入
Brief Report: Proposed clinical trial guidelines based on clinicopathological heterogeneity of metastatic pulmonary large cell neuroendocrine carcinoma (LCNEC)
13小时前
求助中
The pathogenesis of neurological immune-related adverse events following immune checkpoint inhibitor therapy
24天前
已完结
Neurological immune-related adverse events of immune-checkpoint inhibitors: an updated review
24天前
已完结
Outcomes and Treatments of Patients With Non–Small Cell Lung Cancer Who Received Pembrolizumab
24天前
已完结
Metastatic Trajectories in Non–Small Cell Lung Cancer Guide Local and Systemic Therapies
1个月前
已完结
New developments and applications of human organoids
1个月前
已完结
A systematic literature review of MTAP deletions in solid and hematologic Cancers
2个月前
已完结
ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib
2个月前
已完结
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies
2个月前
已完结
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
2个月前
已完结
皖公网安备34019202002308
